Leonteq Securities AG Purchases Shares of 5,696 Danaher Corporation $DHR

Leonteq Securities AG purchased a new stake in Danaher Corporation (NYSE:DHR) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 5,696 shares of the conglomerate’s stock, valued at approximately $1,304,000.

A number of other hedge funds and other institutional investors also recently bought and sold shares of DHR. JPL Wealth Management LLC acquired a new stake in Danaher in the third quarter valued at $25,000. Elevated Capital Advisors LLC acquired a new stake in Danaher in the fourth quarter valued at $26,000. WFA of San Diego LLC acquired a new stake in Danaher in the second quarter valued at $26,000. ANTIPODES PARTNERS Ltd acquired a new stake in Danaher in the third quarter valued at $27,000. Finally, Financial Life Planners acquired a new stake in Danaher in the third quarter valued at $32,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Stock Performance

NYSE DHR opened at $173.51 on Friday. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80. The business’s 50-day moving average price is $183.98 and its 200 day moving average price is $208.99. The firm has a market cap of $122.80 billion, a P/E ratio of 33.56, a P/E/G ratio of 2.29 and a beta of 0.81.

Danaher (NYSE:DHR) last released its quarterly earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.94 by $0.12. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The firm had revenue of $5.95 billion for the quarter, compared to analyst estimates of $6 billion. During the same quarter last year, the company posted $1.88 earnings per share. The business’s revenue was up 3.7% on a year-over-year basis. On average, equities research analysts expect that Danaher Corporation will post 8.43 earnings per share for the current year.

Danaher Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be issued a dividend of $0.40 per share. The ex-dividend date of this dividend is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.9%. Danaher’s dividend payout ratio (DPR) is currently 30.95%.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on DHR. Robert W. Baird dropped their price objective on Danaher from $251.00 to $249.00 and set an “outperform” rating on the stock in a report on Friday, April 17th. Rothschild & Co Redburn set a $205.00 price objective on Danaher in a report on Friday, April 17th. Evercore raised their price objective on Danaher from $225.00 to $232.00 and gave the stock an “outperform” rating in a report on Tuesday, April 21st. UBS Group dropped their price objective on Danaher from $270.00 to $250.00 and set a “buy” rating on the stock in a report on Wednesday, April 22nd. Finally, Guggenheim dropped their price objective on Danaher from $275.00 to $235.00 and set a “buy” rating on the stock in a report on Wednesday, April 22nd. Nineteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, Danaher currently has a consensus rating of “Moderate Buy” and a consensus target price of $238.65.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.